Alcon Inc. (ALC)
NYSE · Common stock
As of Oct 21, 2:16 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow ALC in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on ALC and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
ALC at a glance
Key statistics
$32.79B
Market capitalization
- Previous close
- $67.83
- Open
- $67.54
- Day range
- $67.20 – $68.07
- Volume
- 563.7K
- Average volume (30 sessions)
- 1.77M
- Shares outstanding
- 483.40M
- Price / earnings
- 74.5
- Earnings per share
- $0.91
- Price / book
- 1.7
- Price / sales
- 3.8
- Beta (1 year, vs SPY)
- 0.42
Where the price sits in its year
52-week range
23% of the range
- Below the 52-week high
- -22.7%
- Above the 52-week low
- +9.5%
Completed sessions through Oct 20, 2026
Technical snapshot
Below its 50-day and 200-day averages
- 20-day average
- $64.66+4.9%
- 50-day average
- $68.24-0.6%
- 200-day average
- $72.37-6.3%
Between the conventional 30 and 70 bands.
+7.7%
1 week
+4.6%
1 month
+0.7%
3 months
-13.9%
Year to date
-9.7%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with ALC
ALC on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on ALC.
See the plans →
Every planScreen names like ALC
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on ALC
Put ALC on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on ALC
See whether there is an open premium alert on ALC, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
ALC headlines
- Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others
GlobeNewswire Inc. · Jul 13, 2026
- LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review
Benzinga · Mar 17, 2026
- LENSAR® Provides Update on Pending Acquisition by Alcon
GlobeNewswire Inc. · Feb 25, 2026
- STAAR Surgical Merger With Alcon Fails After Shareholders Vote No
Benzinga · Jan 6, 2026
- STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process
Benzinga · Dec 10, 2025
- New Eye Tech Is Booming For Alcon, Stock Soars
Benzinga · Nov 12, 2025
- Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall
Benzinga · Aug 20, 2025
- Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition
Benzinga · Aug 5, 2025
SEC Form 4, most recent first
Insider filings
Levonowich Walter Alan
−4.0K
VP & Controller · Returned to the company
· Jul 11, 2013
Rhinelander Mel
−10.0K
Director · Returned to the company
· Jul 11, 2013
Roadman Chip
−10.0K
Chief Executive Officer, Director · Returned to the company
· Jul 11, 2013
Hennigar David
−10.0K
Director · Returned to the company
· Jul 11, 2013
Rhinelander Mel
−8.0K
Director · Returned to the company
$29.84K · Jul 11, 2013
Rhinelander Mel
−2.9K
Director · Returned to the company
$34.32K · Jul 11, 2013
Hennigar David
−10.0K
Director · Returned to the company
· Jul 11, 2013
Ng Malen
−8.0K
Director · Returned to the company
$29.84K · Jul 11, 2013
About Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
- Exchange
- NYSE
- Security
- Common stock
- Employees
- 25,942
- Listed since
- Apr 9, 2019
- Website
- alcon.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.